Related Experiment Video
Updated: Jan 15, 2026
Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Hemodynamic and Postoperative Benefits of Remimazolam Over Sevoflurane: A Comparative Meta-Analysis
Ayushi Vashisht1, Aditi Vashisht2, Lokesh Maratha3
1Department of Anaesthesia, Lala Lajpat Rai Memorial Medical College, Meerut, India.
Objective:
To compare remimazolam and sevoflurane in terms of intraoperative hemodynamics, postoperative recovery, and complications during elective surgical procedures.
Design:
A systematic review and meta-analysis conducted according to the PRISMA guidelines.
Setting:
Elective surgeries performed across various healthcare institutions, as reported in studies retrieved from PubMed, Cochrane, Scopus, and Embase databases.
Participants:
A total of 10 studies (6 randomized controlled trials and 4 retrospective studies) involving 864 patients undergoing elective surgical procedures (431 receiving sevoflurane and 433 receiving remimazolam) were included.
Interventions:
Administration of either remimazolam or sevoflurane for maintenance of general anesthesia.
Measurements And Main Results:
Primary outcomes assessed were intraoperative mean arterial pressure (MAP), heart rate (HR), extubation time, quality of recovery (QoR-15), incidence of hypotension, and postoperative nausea and vomiting (PONV). The risk of bias was evaluated using the Newcastle-Ottawa Scale and the Detsky Quality Assessment Scale. Statistical analysis was performed with RevMan 5.4. Remimazolam was associated with higher intraoperative MAP both before (p = 0.05) and after intubation (p = 0.04) and incision (p < 0.0001). The incidence rates of intraoperative hypotension and use of rescue antihypotensive agents were significantly lower in the remimazolam group (p < 0.00001). Additionally, PONV and the requirement for rescue antiemetics were significantly reduced with remimazolam (p = 0.0005 and p = 0.01, respectively). There were no significant differences between the groups in terms of extubation time, QoR-15 scores, and postoperative pain scores.
Conclusions:
Compared to sevoflurane, remimazolam appears to provide more stable intraoperative hemodynamics, a lower risk of hypotension requiring intervention, and faster recovery with fewer PONV episodes. Given the heterogeneity of the included studies, the inclusion of retrospective data, and the overall low to moderate certainty of evidence, these findings should be interpreted with caution. Further high-quality randomized trials are needed to confirm these results.
More Related Videos
14:52Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers
Published on: January 13, 2018
03:02Application of Dixon's Up-and-Down Design to Estimate the Minimum Alveolar Concentration of Sevoflurane in Rats with Refined Movement Classification
Published on: July 25, 2025
Related Concept Videos
01:24Parenteral Anesthetics: Overview
01:20Inhalational Anesthetics: Overview
01:24General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
01:22Stages of General Anesthesia
01:23Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...